This trial is active, not recruiting.

Conditions asystole, bradycardia, hypotension
Sponsor Hackensack University Medical Center
Start date August 2006
End date August 2006
Trial identifier NCT00527709, 06.01.025


This pilot study is being pursued to observe whether certain medications are given to patients within a timeframe where their being given could play a part in a critical event in the management of the patient.

There are general rules about when it would be appropriate for these types of medications not to be given. However, it is not current standard practice for the criteria to be put in place without the expressed wishes of the ordering physician or their agent.

Research Question:

Can the administration of cardio-depressant medications be documented as a significant risk factor for hypotensive or bradycardic events?

United States No locations recruiting
Other countries No locations recruiting

Study Design

Time perspective retrospective

Eligibility Criteria

Male or female participants of any age.

Inclusion Criteria: - Serial evaluation of the first 50 documented events of Code Blue or call to Rapid Response Team involving hypotension, bradycardia or asystole in the adult inpatient population events beginning January 1, 2006.

Additional Information

Official title Hold Parameters on Likely Cardiovascular Depressant Medications (HOLD)
Principal investigator Amit Tailor, MD, MBA
Trial information was received from ClinicalTrials.gov and was last updated in February 2014.
Information provided to ClinicalTrials.gov by Hackensack University Medical Center.